Search

Your search keyword '"Del Vecchio, Lucia"' showing total 666 results

Search Constraints

Start Over You searched for: Author "Del Vecchio, Lucia" Remove constraint Author: "Del Vecchio, Lucia"
666 results on '"Del Vecchio, Lucia"'

Search Results

1. The safety of corticosteroid therapy in IGA nephropathy: analysis of a real-life Italian cohort

4. A meta-analysis of GFR slope as a surrogate endpoint for kidney failure

5. Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy

6. Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

7. Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

9. The Role of Rituximab in Primary Focal Segmental Glomerular Sclerosis of the Adult

10. Efficacy and Safety of Roxadustat in Patients with CKD: Pooled Analysis by Baseline Inflammation Status.

11. Update on current and emerging treatment paradigms for hyperphosphatemia in chronic kidney disease.

12. Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKD

19. Budget impact analysis on the Italian healthcare system of roxadustat for the treatment of anemia due to chronic kidney disease

22. Method Comparison of Erythrocyte Sedimentation Rate Automated Systems, the VES-MATIC 5 (DIESSE) and Test 1 (ALIFAX), with the Reference Method in Routine Practice

24. Can we effectively manage chronic kidney disease with a precision-based pharmacotherapy plan? Where are we?

25. Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials

27. Erythropoietin in Kidney Disease and Type 2 Diabetes

28. Darbepoetin alfa and chronic kidney disease.

29. α- and β-Adducin polymorphisms affect podocyte proteins and proteinuria in rodents and decline of renal function in human IgA nephropathy

30. alpha- and beta-Adducin polymorphisms affect podocyte proteins and proteinuria in rodents and decline of renal function in human IgA nephropathy.

31. Effect of Antidiabetic Drugs on Bone Health in Patients with Normal Renal Function and in Chronic Kidney Disease (CKD): Insight into Clinical Challenges in the Treatment of Type 2 Diabetes

33. Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial

37. A Peculiar CLL Case with Complex Chromosome 6 Rearrangements and Refinement of All Breakpoints at the Gene Level by Genomic Array: A Case Report

41. Early Change in Urine Protein as a Surrogate End Point in Studies of IgA Nephropathy: An Individual-Patient Meta-analysis

43. Contributors

44. Analisi di impatto sul budget sanitario italiano di roxadustat per il trattamento dell'anemia da malattia renale cronica.

45. SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERA

46. Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

47. Novel Anemia Therapies in CKD: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Catalog

Books, media, physical & digital resources